মহেশপুর সীমান্ত থেকে মাদকসহ চোরাকারবারি আটক
| 653711| bd-pratidin.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bd-pratidin.com Daily Mail and Mail on Sunday newspapers.
Updated:
Dr. Lahariya counters figure projected by government.
Share Article
AAA
A tribal head taking the vaccine at Anaikatti village in Nilgiris district, Tamil Nadu. File photo
| Photo Credit: M. Sathyamoorthy
Dr. Lahariya counters figure projected by government.
India ought to realistically expect around a 1.3 billion doses of vaccines from August to December and not the 2 billion that the Centre has projected, said epidemiologist, public health expert and author Dr. Chandrakant Lahariya, in an interview to
The Hindu.
The estimate that had been made by Dr. V.K. Paul, who heads India’s COVID-19 task force, is premised on vaccines from eight companies. Four of those vaccines (Biological E, Zydus Cadila, Genova Biopharma and Bharat Biotech Nasal) are in various phases of clinical trials, some in phase 1-2, said Dr. Lahariya and their success and eventual licensing could not be predetermined.
From operating puny units in the 1990s, leading Indian pharmaceutical companies have seen a dream run. Through challenges, there came opportunities. Industry leaders like Yusuf Hamied, Dilip Shanghvi, and Pankaj Patel did what they could do best with limited resources.
But will that be good enough to grow from here on? Can generic drugs alone fuel growth? Can India ever develop a blockbuster drug something that has been elusive for so long? That’s where young leaders come in unlearning and learning as they think differently on how to do things. Let’s try and understand how young minds are working and challenging the status quo.
1057 LARGER SCOPE: Chinaâs role in Chabahar should be seen beyond the Delhi-Beijing tug of war. Reuters
ABHIJIT BHATTACHARYYA
Commentator and Author
IN hindsight, the recent statement of Iranian Foreign Minister Javad Zarif wasn’t unexpected: “China wants to play a role in the Chabahar (port) project”. It’s Iran’s nudge to India about the arrival of Beijing in a territory where New Delhi enjoyed prime privilege for some time. Does it constitute a major breakthrough by the Communist Party of China (CPC) by creating a coveted space for itself to counter and confront India in a strategic seaport in a third country? Can India avoid future pressure and tensions in a long, connected terrain spanning Pakistan, Iran and Turkey?